|
|
42
|
|
|
A7513
|
|
|
SANDOSTATIN LAR 20MG INJ (NVS) OCTREOTID
|
|
|
OCTREOTIDE
|
|
|
SANDOSTATIN LAR
|
|
|
20MG VIAL
|
|
|
BQ
|
|
|
3,860.02
|
|
|
3,860.02
|
|
|
20MG
|
|
|
VIAL
|
|
|
20
|
|
|
VIAL
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
AVENTA BARBADOS
|
|
|
|
|
|
Anti-Neoplastic
|
|
|
2026-04-01
|
|
|
2028-03-31
|
|
|
No
|
|
|
No
|
|
|
|
|
|
0
|
|
|
N
|
|
|
9292
|
|
|
OTHER THERAPEUTIC AGENTS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
OTHER THERAPEUTIC AGENTS
|
|
|
|